UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (10) 10
science & technology (10) 10
hiv (6) 6
humans (5) 5
once daily (5) 5
once-daily (5) 5
raltegravir (5) 5
adult (4) 4
antiretroviral drugs (4) 4
dolutegravir (4) 4
highly active antiretroviral therapy (4) 4
hiv infection (4) 4
hiv-1 (4) 4
human immunodeficiency virus--hiv (4) 4
infectious diseases (4) 4
male (4) 4
pharmacology & pharmacy (4) 4
analysis (3) 3
anti-hiv agents - administration & dosage (3) 3
antiretroviral therapy (3) 3
antiviral agents (3) 3
drug therapy (3) 3
emtricitabine (3) 3
female (3) 3
general & internal medicine (3) 3
hiv infections - drug therapy (3) 3
medicine, general & internal (3) 3
pharmacokinetics (3) 3
administration, oral (2) 2
aids/hiv (2) 2
antiretroviral (2) 2
area under curve (2) 2
clinical science (2) 2
darunavir (2) 2
drug administration schedule (2) 2
drug combinations (2) 2
drug-resistance (2) 2
elvitegravir (2) 2
fixed-dose combination (2) 2
hiv integrase inhibitors - pharmacokinetics (2) 2
hiv-1 infection (2) 2
immunology (2) 2
infectious medicine (2) 2
infektionsmedicin (2) 2
initial treatment (2) 2
integrase inhibitors (2) 2
interaction (2) 2
middle aged (2) 2
once-daily dolutegravir (2) 2
once-daily dosing (2) 2
once‐daily (2) 2
patient preference and adherence (2) 2
physiological aspects (2) 2
raltegravir potassium - administration & dosage (2) 2
raltegravir potassium - blood (2) 2
review (2) 2
safety (2) 2
single-tablet regimen (2) 2
[sdv.imm]life sciences [q-bio]/immunology (1) 1
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (1) 1
[sdv.mp.vir]life sciences [q-bio]/microbiology and parasitology/virology (1) 1
abacavir-lamivudine (1) 1
absorption (1) 1
acetals - chemistry (1) 1
adherence (1) 1
adults (1) 1
aluminium and magnesium hydroxide (1) 1
aluminum hydroxide - administration & dosage (1) 1
aluminum hydroxide - adverse effects (1) 1
animals (1) 1
antacids (1) 1
antacids - administration & dosage (1) 1
antacids - adverse effects (1) 1
anti-hiv agents - blood (1) 1
anti-hiv agents - therapeutic use (1) 1
antibiotics (1) 1
antiretroviral therapy, highly active (1) 1
antiretroviral-naive (1) 1
antiretroviral-naive adults (1) 1
belgium (1) 1
belgium - epidemiology (1) 1
benzoxazines - administration & dosage (1) 1
benzoxazines - blood (1) 1
bioavailability (1) 1
boosted protease inhibitors (1) 1
calcium carbonate (1) 1
calcium carbonate - administration & dosage (1) 1
calcium carbonate - adverse effects (1) 1
carbonates (1) 1
carbonates - chemistry (1) 1
cd4 antigen (1) 1
cervical intraepithelial neoplasia (1) 1
clinical trials (1) 1
co-formulated single-table regimen (1) 1
cobicistat (1) 1
colonic absorption (1) 1
comparative analysis (1) 1
confidence intervals (1) 1
containing regimens (1) 1
controlled-release formulation (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HIV/AIDS (Auckland), ISSN 1179-1373, 02/2013, Volume 5, pp. 29 - 40
.... Dolutegravir is an investigational next-generation integrase inhibitor showing some novel and intriguing characteristics, ie, it has a favorable pharmacokinetic profile with a prolonged intracellular... 
Antiretroviral drugs | Integrase inhibitors | HIV-1 integrase | Dolutegravir | Once daily | Drug therapy | HIV infection | integrase inhibitors | once daily | antiretroviral drugs | dolutegravir
Journal Article
7/2014, Volume 5, Issue 4
...) are now considered an alternative ‘third agent’ class of antiretroviral (ARV) drugs. Dolutegravir is the first next-generation INSTI showing some novel and intriguing characteristics... 
HIV-1 | integrase inhibitors | antiretroviral drugs | once-daily dosing | dolutegravir | Reviews
Book Review
Journal Article
Journal des anti-infectieux, ISSN 2210-6545, 09/2014, Volume 16, Issue 3, pp. 137 - 143
... (efavirenz or rilpivirine), integrase inhibitors (cobicistat-boosted elvitegravir or dolutegravir... 
Single-tablet regimen | Antiretroviral | Once-daily
Journal Article
Journal of pharmacy and pharmacology, ISSN 0022-3573, 11/2016, Volume 68, Issue 11, pp. 1359 - 1365
Objectives Raltegravir is a human immunodeficiency virus (HIV)‐1 integrase strand transfer inhibitor currently marketed at a dose of 400 mg twice daily (BID).... 
interaction | pharmacokinetics | calcium carbonate | once‐daily | aluminium and magnesium hydroxide | once-daily | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Raltegravir Potassium - adverse effects | Area Under Curve | Magnesium - administration & dosage | Humans | Middle Aged | Raltegravir Potassium - administration & dosage | Male | Metabolic Clearance Rate | Aluminum Hydroxide - administration & dosage | HIV Integrase Inhibitors - administration & dosage | Drug Interactions | Polypharmacy | Antacids - adverse effects | HIV Infections - diagnosis | Adult | Female | Calcium Carbonate - administration & dosage | Magnesium - adverse effects | Raltegravir Potassium - pharmacokinetics | Drug Administration Schedule | Administration, Oral | HIV Infections - virology | HIV Integrase Inhibitors - pharmacokinetics | Magnesium Hydroxide - adverse effects | Calcium Carbonate - adverse effects | Aluminum Hydroxide - adverse effects | Magnesium Hydroxide - administration & dosage | HIV Integrase Inhibitors - adverse effects | Raltegravir Potassium - blood | HIV Infections - drug therapy | HIV Integrase Inhibitors - blood | Antacids - administration & dosage | Drug Combinations | Urine | Antiviral agents | Analysis | Electrocardiogram | Calcium carbonate | Electrocardiography | Magnesium hydroxide | HIV (Viruses) | Human immunodeficiency virus--HIV | Antacids | Magnesium | Index Medicus
Journal Article
Clinical pharmacology in drug development, ISSN 2160-763X, 02/2018, Volume 7, Issue 2, pp. 196 - 206
A new once‐daily formulation of raltegravir, an integrase strand transfer inhibitor indicated in combination with other antiretroviral drugs for the treatment... 
raltegravir | pharmacokinetics | once daily | absorption | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmacology | Bioavailability | Index Medicus
Journal Article
Patient preference and adherence, ISSN 1177-889X, 2011, Volume 5, pp. 645 - 651
Journal Article